You are here

Global

Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports

Thu, 2021-01-21 14:56 — mike kraft

Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced. Karen Weintraub USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
Log in or register to post comments

South African study: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

Wed, 2021-01-20 21:03 — mike kraft

New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of the current line of vaccines, scientists said on Wednesday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about South African study: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy
Log in or register to post comments

British Study: Airborne virus can spread 6 feet within seconds through talking

Wed, 2021-01-20 20:42 — mike kraft

Coronavirus updates: COVID-19 can spread within seconds through talking, study says; Some states, Canada report vaccine shortages Some states report they are running out of vaccines. The U.K. suffered its deadliest day of the pandemic on Tuesday. Latest COVID-19 news. Elinor Aspegren, Adrianna Rodriguez and Doyle Rice USA TODAY

Study: Airborne virus can spread 6 feet within seconds through talking

Country / Region Tags:

General Topic Tags:

Social distancing

Problem, Solution, SitRep, or ?:

Read more about British Study: Airborne virus can spread 6 feet within seconds through talking
Log in or register to post comments

Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates

Wed, 2021-01-20 13:37 — mike kraft

Study: Pfizer Covid-19 vaccine effective with variant first detected in U.K. The paper is a welcome signal that existing vaccines don’t seem to be weakened by the variant in question, known as B.1.1.7. Andrew Joseph STAT

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

WHO plans slew of COVID-19 vaccine approvals for global rollout - document

Wed, 2021-01-20 11:01 — mike kraft

Exclusive: WHO plans slew of COVID-19 vaccine approvals for global rollout - document The World Health Organization (WHO) plans to approve several COVID-19 vaccines from Western and Chinese manufacturers in the coming weeks and months, an internal document seen by Reuters shows, as it aims for rapid rollouts in poorer countries. Francesco Guarascio U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO plans slew of COVID-19 vaccine approvals for global rollout - document
Log in or register to post comments

Electric car batteries with five-minute charging times produced

Tue, 2021-01-19 20:20 — mike kraft

Electric car batteries with five-minute charging times produced Exclusive: first factory production means recharging could soon be as fast as filling up petrol or diesel vehicles the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Electric car batteries with five-minute charging times produced
Log in or register to post comments

“Anytime when you have mutations that come up independently of each other in multiple places, it’s really a sign,” says Vineet Menachery, a coronavirus researcher at the University of Texas Medical Branch. Now scientists are scrambling to figure out if an

Tue, 2021-01-19 17:54 — mike kraft

A Troubling New Pattern Among the Coronavirus Variants The most concerning versions of the virus are not simply mutating—they’re mutating in similar ways. Sarah Zhang The Atlantic

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Three questions and the emerging answers about COVID-19 Vaccine protection--NPR

Tue, 2021-01-19 11:05 — mike kraft

As the COVID-19 vaccine rolls out, three big questions loom. First, can someone who has been vaccinated still spread the disease? Second, will the vaccine remain effective as the virus itself evolves? And third, how long will the vaccine's protection last?

Answers to these questions lie in our immune systems. And the answers aren't straightforward because our immune systems are both remarkably adept and remarkably challenging to predict.

...the first question, about whether people who are vaccinated can still spread the disease. Marion Pepper, an immunologist at the University of Washington, says that's not just an open question for this vaccine, but for vaccines in general.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Three questions and the emerging answers about COVID-19 Vaccine protection--NPR
Log in or register to post comments

WORLD OVERVIEW: Roundup of Developments in Coronavirus situation

Tue, 2021-01-19 09:45 — mike kraft

Asia Today: China sees virus outbreaks across its northeast BEIJING (AP) — China was dealing with coronavirus outbreaks across its frigid northeast on Tuesday, prompting additional lockdowns and travel bans ahead of next month's Lunar New Year holiday.... AP NEWS

BEIJING (AP) — China was dealing with coronavirus outbreaks across its frigid northeast on Tuesday, prompting additional lockdowns and travel bans ahead of next month’s Lunar New Year holiday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WORLD OVERVIEW: Roundup of Developments in Coronavirus situation
Log in or register to post comments

Pages